Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 10/10

vs
industry
vs
history
Cash-to-Debt No Debt
OSUR's Cash-to-Debt is ranked higher than
95% of the 205 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.74 vs. OSUR: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
OSUR' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.4  Med: 20.59 Max: No Debt
Current: No Debt
0.4
No Debt
Equity-to-Asset 0.91
OSUR's Equity-to-Asset is ranked higher than
89% of the 196 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. OSUR: 0.91 )
Ranked among companies with meaningful Equity-to-Asset only.
OSUR' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.55  Med: 0.84 Max: 0.96
Current: 0.91
0.55
0.96
Interest Coverage No Debt
OSUR's Interest Coverage is ranked higher than
93% of the 137 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 63.92 vs. OSUR: No Debt )
Ranked among companies with meaningful Interest Coverage only.
OSUR' s Interest Coverage Range Over the Past 10 Years
Min: No Debt  Med: No Debt Max: No Debt
Current: No Debt
Piotroski F-Score: 5
Altman Z-Score: 21.00
Beneish M-Score: -1.92
WACC vs ROIC
13.85%
14.28%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 5/10

vs
industry
vs
history
Operating Margin % 12.53
OSUR's Operating Margin % is ranked higher than
90% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.41 vs. OSUR: 12.53 )
Ranked among companies with meaningful Operating Margin % only.
OSUR' s Operating Margin % Range Over the Past 10 Years
Min: -20.68  Med: -8.58 Max: 16.6
Current: 12.53
-20.68
16.6
Net Margin % 8.38
OSUR's Net Margin % is ranked higher than
87% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.18 vs. OSUR: 8.38 )
Ranked among companies with meaningful Net Margin % only.
OSUR' s Net Margin % Range Over the Past 10 Years
Min: -43.98  Med: -7.4 Max: 18.52
Current: 8.38
-43.98
18.52
ROE % 5.98
OSUR's ROE % is ranked higher than
72% of the 198 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.43 vs. OSUR: 5.98 )
Ranked among companies with meaningful ROE % only.
OSUR' s ROE % Range Over the Past 10 Years
Min: -25.18  Med: -5.07 Max: 13.94
Current: 5.98
-25.18
13.94
ROA % 5.33
OSUR's ROA % is ranked higher than
85% of the 206 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. OSUR: 5.33 )
Ranked among companies with meaningful ROA % only.
OSUR' s ROA % Range Over the Past 10 Years
Min: -20.9  Med: -4.38 Max: 12.28
Current: 5.33
-20.9
12.28
ROC (Joel Greenblatt) % 43.61
OSUR's ROC (Joel Greenblatt) % is ranked higher than
93% of the 204 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.63 vs. OSUR: 43.61 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
OSUR' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -68.81  Med: -26.96 Max: 57.68
Current: 43.61
-68.81
57.68
3-Year Revenue Growth Rate 12.90
OSUR's 3-Year Revenue Growth Rate is ranked higher than
77% of the 170 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. OSUR: 12.90 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
OSUR' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -15.7  Med: 6.45 Max: 64.2
Current: 12.9
-15.7
64.2
GuruFocus has detected 1 Warning Sign with OraSure Technologies Inc OSUR.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» OSUR's 30-Y Financials

Financials (Next Earnings Date: 2018-11-01 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2017

OSUR Guru Trades in Q3 2017

Chuck Royce 210,338 sh (+0.16%)
PRIMECAP Management 1,259,000 sh (-0.08%)
Jim Simons 4,682,703 sh (-8.25%)
Mariko Gordon 2,570,660 sh (-8.89%)
Joel Greenblatt 13,555 sh (-14.79%)
Ken Fisher 556,455 sh (-18.47%)
Columbia Wanger 321,584 sh (-51.27%)
» More
Q4 2017

OSUR Guru Trades in Q4 2017

Paul Tudor Jones 12,473 sh (New)
Mariko Gordon 3,038,215 sh (+18.19%)
Columbia Wanger 376,174 sh (+16.98%)
Ken Fisher 627,828 sh (+12.83%)
PRIMECAP Management 1,266,000 sh (+0.56%)
Chuck Royce 210,455 sh (+0.06%)
Joel Greenblatt Sold Out
Jim Simons 4,003,100 sh (-14.51%)
» More
Q1 2018

OSUR Guru Trades in Q1 2018

Jim Simons 4,074,303 sh (+1.78%)
PRIMECAP Management 1,266,000 sh (unchged)
Paul Tudor Jones Sold Out
Mariko Gordon 2,934,412 sh (-3.42%)
Ken Fisher 597,584 sh (-4.82%)
Chuck Royce 152,422 sh (-27.58%)
» More
Q2 2018

OSUR Guru Trades in Q2 2018

Steven Cohen 7,400 sh (New)
PRIMECAP Management 1,494,000 sh (+18.01%)
Mariko Gordon 2,834,695 sh (-3.40%)
Jim Simons 3,895,203 sh (-4.40%)
Ken Fisher 399,356 sh (-33.17%)
Chuck Royce 50,790 sh (-66.68%)
» More
» Details

Insider Trades

Latest Guru Trades with NAS:OSUR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mariko Gordon 2018-06-30 Reduce -3.40%0.11%$14.46 - $18.08 $ 14.77-13%2,834,695
Ken Fisher 2018-06-30 Reduce -33.17%$14.46 - $18.08 $ 14.77-13%399,356
Mariko Gordon 2018-03-31 Reduce -3.42%0.12%$16.77 - $22.04 $ 14.77-22%2,934,412
Ken Fisher 2018-03-31 Reduce -4.82%$16.77 - $22.04 $ 14.77-22%597,584
Mariko Gordon 2017-12-31 Add 18.19%0.55%$13.44 - $22.81 $ 14.77-19%3,038,215
Ken Fisher 2017-12-31 Add 12.83%$13.44 - $22.81 $ 14.77-19%627,828
Joel Greenblatt 2017-12-31 Sold Out $13.44 - $22.81 $ 14.77-19%0
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:NYSE:GKOS, XMCE:FAE, NAS:ATRI, XKLS:7153, SZSE:300061, NAS:LMNX, LSE:AMS, TSE:7780, ROCO:1565, TSE:3593, SZSE:300358, TSE:7730, SZSE:300595, NAS:IRTC, SZSE:300171, NAS:ATRC, XKRX:048260, NAS:ANGO, SHSE:600288, NAS:STAA » details
Traded in other countries:EP3.Germany,
Headquarter Location:USA
OraSure Technologies Inc develops, manufactures, markets and sells oral fluid diagnostic products and specimen collection devices using its proprietary oral fluid technologies.

OraSure Technologies Inc manufactures oral fluid diagnostic products and specimen-collection devices, as well as diagnostic products used on other specimen types and medical devices used to remove benign skin lesions. The firm operates in two segments: OSUR and DNAG. The OSUR business contributes the majority of revenue and sells diagnostic products, specimen collection devices, and medical devices. This segment also receives revenue from the sale of over-the-counter products to retail pharmacies and mass merchandisers. The DNAG business sells oral fluid collection devices used to collect samples of genetic material for molecular testing. OraSure generates the majority of its revenue in the United States.

Ratios

vs
industry
vs
history
PE Ratio 59.08
OSUR's PE Ratio is ranked lower than
62% of the 125 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.70 vs. OSUR: 59.08 )
Ranked among companies with meaningful PE Ratio only.
OSUR' s PE Ratio Range Over the Past 10 Years
Min: 21.29  Med: 59.56 Max: 500.83
Current: 59.08
21.29
500.83
Forward PE Ratio 30.77
OSUR's Forward PE Ratio is ranked lower than
90% of the 40 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 26.32 vs. OSUR: 30.77 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 59.08
OSUR's PE Ratio without NRI is ranked lower than
60% of the 123 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. OSUR: 59.08 )
Ranked among companies with meaningful PE Ratio without NRI only.
OSUR' s PE Ratio without NRI Range Over the Past 10 Years
Min: 21.29  Med: 59.56 Max: 500.83
Current: 59.08
21.29
500.83
Price-to-Owner-Earnings 343.49
OSUR's Price-to-Owner-Earnings is ranked lower than
78% of the 83 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 30.92 vs. OSUR: 343.49 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
OSUR' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 12.73  Med: 53.89 Max: 2826.67
Current: 343.49
12.73
2826.67
PB Ratio 3.40
OSUR's PB Ratio is ranked lower than
61% of the 193 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.45 vs. OSUR: 3.40 )
Ranked among companies with meaningful PB Ratio only.
OSUR' s PB Ratio Range Over the Past 10 Years
Min: 0.94  Med: 2.45 Max: 6.45
Current: 3.4
0.94
6.45
PS Ratio 5.08
OSUR's PS Ratio is ranked lower than
73% of the 192 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.48 vs. OSUR: 5.08 )
Ranked among companies with meaningful PS Ratio only.
OSUR' s PS Ratio Range Over the Past 10 Years
Min: 1.53  Med: 3.8 Max: 9.03
Current: 5.08
1.53
9.03
Price-to-Free-Cash-Flow 69.02
OSUR's Price-to-Free-Cash-Flow is ranked lower than
69% of the 74 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 28.61 vs. OSUR: 69.02 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
OSUR' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 11.44  Med: 52.88 Max: 233.59
Current: 69.02
11.44
233.59
Price-to-Operating-Cash-Flow 44.76
OSUR's Price-to-Operating-Cash-Flow is ranked lower than
77% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 21.15 vs. OSUR: 44.76 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
OSUR' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.73  Med: 38.38 Max: 2795
Current: 44.76
9.73
2795
EV-to-EBIT 33.64
OSUR's EV-to-EBIT is ranked higher than
51% of the 121 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 23.93 vs. OSUR: 33.64 )
Ranked among companies with meaningful EV-to-EBIT only.
OSUR' s EV-to-EBIT Range Over the Past 10 Years
Min: -279.1  Med: -13.8 Max: 332.8
Current: 33.64
-279.1
332.8
EV-to-EBITDA 25.45
OSUR's EV-to-EBITDA is ranked lower than
53% of the 138 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.49 vs. OSUR: 25.45 )
Ranked among companies with meaningful EV-to-EBITDA only.
OSUR' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1517.9  Med: -16.15 Max: 275.2
Current: 25.45
-1517.9
275.2
EV-to-Revenue 4.21
OSUR's EV-to-Revenue is ranked lower than
67% of the 199 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.57 vs. OSUR: 4.21 )
Ranked among companies with meaningful EV-to-Revenue only.
OSUR' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.5  Med: 2.9 Max: 8.3
Current: 4.21
0.5
8.3
Current Ratio 9.58
OSUR's Current Ratio is ranked higher than
88% of the 200 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.57 vs. OSUR: 9.58 )
Ranked among companies with meaningful Current Ratio only.
OSUR' s Current Ratio Range Over the Past 10 Years
Min: 2.34  Med: 7.22 Max: 20
Current: 9.58
2.34
20
Quick Ratio 8.60
OSUR's Quick Ratio is ranked higher than
90% of the 201 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.87 vs. OSUR: 8.60 )
Ranked among companies with meaningful Quick Ratio only.
OSUR' s Quick Ratio Range Over the Past 10 Years
Min: 1.87  Med: 6.46 Max: 18
Current: 8.6
1.87
18
Days Inventory 88.12
OSUR's Days Inventory is ranked higher than
76% of the 197 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.35 vs. OSUR: 88.12 )
Ranked among companies with meaningful Days Inventory only.
OSUR' s Days Inventory Range Over the Past 10 Years
Min: 83.45  Med: 116.55 Max: 134.26
Current: 88.12
83.45
134.26
Days Sales Outstanding 64.19
OSUR's Days Sales Outstanding is ranked lower than
80% of the 165 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.97 vs. OSUR: 64.19 )
Ranked among companies with meaningful Days Sales Outstanding only.
OSUR' s Days Sales Outstanding Range Over the Past 10 Years
Min: 47.8  Med: 60.04 Max: 92.9
Current: 64.19
47.8
92.9
Days Payable 46.13
OSUR's Days Payable is ranked higher than
51% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 54.66 vs. OSUR: 46.13 )
Ranked among companies with meaningful Days Payable only.
OSUR' s Days Payable Range Over the Past 10 Years
Min: 38.26  Med: 45.41 Max: 65.49
Current: 46.13
38.26
65.49

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -2.60
OSUR's 3-Year Average Share Buyback Ratio is ranked higher than
58% of the 143 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -5.00 vs. OSUR: -2.60 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
OSUR' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -40.2  Med: -6.2 Max: 11
Current: -2.6
-40.2
11

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 7.65
OSUR's Price-to-Net-Cash is ranked higher than
67% of the 49 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 13.15 vs. OSUR: 7.65 )
Ranked among companies with meaningful Price-to-Net-Cash only.
OSUR' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 1.89  Med: 8.32 Max: 173.78
Current: 7.65
1.89
173.78
Price-to-Net-Current-Asset-Value 5.15
OSUR's Price-to-Net-Current-Asset-Value is ranked higher than
65% of the 124 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.83 vs. OSUR: 5.15 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
OSUR' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 1.4  Med: 7.81 Max: 56.48
Current: 5.15
1.4
56.48
Price-to-Tangible-Book 3.77
OSUR's Price-to-Tangible-Book is ranked higher than
50% of the 167 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.77 vs. OSUR: 3.77 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
OSUR' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.11  Med: 6.56 Max: 29.57
Current: 3.77
1.11
29.57
Price-to-Intrinsic-Value-Projected-FCF 2.60
OSUR's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
67% of the 75 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.41 vs. OSUR: 2.60 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
OSUR' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.14  Med: 3.46 Max: 21.2
Current: 2.6
1.14
21.2
Price-to-Median-PS-Value 1.34
OSUR's Price-to-Median-PS-Value is ranked lower than
79% of the 160 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.13 vs. OSUR: 1.34 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
OSUR' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.44  Med: 1.84 Max: 23.51
Current: 1.34
0.44
23.51
Price-to-Graham-Number 3.14
OSUR's Price-to-Graham-Number is ranked higher than
50% of the 94 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.77 vs. OSUR: 3.14 )
Ranked among companies with meaningful Price-to-Graham-Number only.
OSUR' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 1.4  Med: 3.6 Max: 20.7
Current: 3.14
1.4
20.7
Earnings Yield (Greenblatt) % 2.97
OSUR's Earnings Yield (Greenblatt) % is ranked higher than
71% of the 207 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.40 vs. OSUR: 2.97 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
OSUR' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -21  Med: -2.3 Max: 6.1
Current: 2.97
-21
6.1

More Statistics

Revenue (TTM) (Mil) $179.95
EPS (TTM) $ 0.25
Beta1.78
Volatility37.48%
52-Week Range $12.86 - 22.22
Shares Outstanding (Mil)61.17

Analyst Estimate

Dec18 Dec19 Dec20 Dec21
Revenue (Mil $) 184 201 231 250
EBIT (Mil $)
EBITDA (Mil $)
EPS ($) 0.30 0.47 0.63 0.76
EPS without NRI ($) 0.30 0.47 0.63 0.76
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 55
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyY
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}